CAPPS VICKIE L 4
4 · Orthofix Medical Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Orthofix (OFIX) Director Vickie Capps Receives 14,965-Share Award
What Happened
Vickie L. Capps, a director of Orthofix Medical Inc. (OFIX), received an award of 14,965 deferred stock units (DSUs) on June 10, 2026. The units were granted at $0.00 per share (no cash exchanged). These DSUs are a contingent right to receive one share of common stock per unit once they vest.
Key Details
- Transaction type: Award/Grant (code A) of 14,965 deferred stock units on 2026-06-10. Price per unit: $0.00. Report filed 2026-06-12.
- Vesting: DSUs vest in full on the first anniversary of the grant date (subject to continued service). Per footnote, each DSU represents a contingent right to one common share; vested DSUs convert into common stock within 45 days of the reporting person’s termination of service.
- Shares/units beneficially owned after this grant: 37,649 total (includes 21,934 previously reported DSUs and 750 shares acquired under Orthofix’s Stock Purchase Plan on 4/30/2026, plus the 14,965 DSUs just granted).
- Footnotes: F1 describes vesting and settlement terms for the DSUs. F2 notes prior DSUs and the 4/30/2026 Stock Purchase Plan shares (SPP acquisitions are exempt from Section 16(b)).
- Timeliness: Filing covers a 6/10/2026 grant and was filed on 6/12/2026 — appears timely (within typical Section 16 reporting windows).
Context
Deferred stock units are a form of equity compensation that do not result in immediate share issuance or cash proceeds; they align director compensation with long-term equity performance and require continued service to vest. This is an award, not an open-market purchase or sale, and therefore is a routine compensation-related transaction rather than an explicit buy or sell signal.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-10+14,965→ 43,300 total
Footnotes (2)
- [F1]Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
- [F2]Includes 21,934 previously reported deferred stock units and 750 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).